Decoy Therapeutics Inc. (DCOY) › Shareholders' EquityDecoy Therapeutics Inc. (DCOY) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2014: -$6.54M2015: $92.19M2016: $59.32M2017: -$2.90M2018: -$1.27M2019: $10.58M2020: $22.16M2021: $38.72M2022: $10.38M2023: $5.29M2024: $1.51M2025: $5.89M$5.89M2014Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$5.89M+289.6%2024$1.51M-71.4%2023$5.29M-49.1%2022$10.38M-73.2%2021$38.72M+74.7%2020$22.16M+109.4%2019$10.58M+932.4%2018-$1.27M+56.2%2017-$2.90M-104.9%2016$59.32M-35.7%2015$92.19M+1510.0%2014-$6.54M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share